JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Sacroiliitis in juvenile chronic arthritis. A 10-year follow-up.

66 children with early juvenile chronic arthritis underwent HLA A and B typing in 1974; 16 carried HLA B27. Ten of these had a pauciarticular onset, 3 systemic and 3 poly-articular. At follow-up 10 years later bilateral sacroiliitis had developed in 9 of the 16 B27 positive children, all of whom had a pauciarticular onset. Males predominated and these children had an older age of onset and a predominantly lower limb arthropathy. Enthesopathy and acute iritis further distinguished this group clinically. Other sacroiliac changes, usually simple fusion associated with severe hip involvement, were seen in 7 of the patients, 6 were girls and 6 were HLA B27 negative. Back pain and limitation had developed in 5 children, 4 of whom were B27 positive, after an average of 8 years' disease and at a mean age of 17.3 years. It is concluded that the presence of HLA B27 in boys aged 9 or over, with an onset of pauciarticular disease, signifies that they belong to the spondylitic group.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app